本轮融资由OrbiMed领投,新投资者包括BlackRock Health Sciences、Casdin Capital、Janus Henderson、Samsara BioCapital和Surveyor Capital,现有投资者Foresite Capital、GV、S-Cubed Capital、Sobrato Capital、SR One、Third Rock Ventures等跟投。